Extracorporeal apheresis for neurological, visual, and auditory disorders
Record ID 32008000017
English
Authors' objectives:
Extracorporeal apheresis is a process to remove a specific component from a patient's blood, which is implicated in the pathogenesis of disease. Apheresis is performed with a device, such as an automated blood cell separator or an affinity column, which uses whole blood, retains one or more of the components, and returns the remainder of the blood to the donor. The theoretical benefit of apheresis is that the decrease in the concentration of a harmful plasma constituent will improve the disease course.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=6962
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Blood Component Removal
- Nervous System Diseases
- Vision Disorders
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.